Copyright Reports & Markets. All rights reserved.

Global Gaucher Disease Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Gaucher Disease Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Enzyme Replacement Therapy
      • 1.4.3 Substrate Reduction Therapy
    • 1.5 Market by Application
      • 1.5.1 Global Gaucher Disease Market Share by Application (2014-2025)
      • 1.5.2 Non-Neuronopathic Gaucher Disease
      • 1.5.3 Neuronopathic Gaucher Disease
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Gaucher Disease Market Size
    • 2.2 Gaucher Disease Growth Trends by Regions
      • 2.2.1 Gaucher Disease Market Size by Regions (2014-2025)
      • 2.2.2 Gaucher Disease Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Gaucher Disease Market Size by Manufacturers
      • 3.1.1 Global Gaucher Disease Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Gaucher Disease Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Gaucher Disease Market Concentration Ratio (CR5 and HHI)
    • 3.2 Gaucher Disease Key Players Head office and Area Served
    • 3.3 Key Players Gaucher Disease Product/Solution/Service
    • 3.4 Date of Enter into Gaucher Disease Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Gaucher Disease Market Size by Type (2014-2019)
    • 4.2 Global Gaucher Disease Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Gaucher Disease Market Size (2014-2019)
    • 5.2 Gaucher Disease Key Players in United States
    • 5.3 United States Gaucher Disease Market Size by Type
    • 5.4 United States Gaucher Disease Market Size by Application

    6 Europe

    • 6.1 Europe Gaucher Disease Market Size (2014-2019)
    • 6.2 Gaucher Disease Key Players in Europe
    • 6.3 Europe Gaucher Disease Market Size by Type
    • 6.4 Europe Gaucher Disease Market Size by Application

    7 China

    • 7.1 China Gaucher Disease Market Size (2014-2019)
    • 7.2 Gaucher Disease Key Players in China
    • 7.3 China Gaucher Disease Market Size by Type
    • 7.4 China Gaucher Disease Market Size by Application

    8 Japan

    • 8.1 Japan Gaucher Disease Market Size (2014-2019)
    • 8.2 Gaucher Disease Key Players in Japan
    • 8.3 Japan Gaucher Disease Market Size by Type
    • 8.4 Japan Gaucher Disease Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Gaucher Disease Market Size (2014-2019)
    • 9.2 Gaucher Disease Key Players in Southeast Asia
    • 9.3 Southeast Asia Gaucher Disease Market Size by Type
    • 9.4 Southeast Asia Gaucher Disease Market Size by Application

    10 India

    • 10.1 India Gaucher Disease Market Size (2014-2019)
    • 10.2 Gaucher Disease Key Players in India
    • 10.3 India Gaucher Disease Market Size by Type
    • 10.4 India Gaucher Disease Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Gaucher Disease Market Size (2014-2019)
    • 11.2 Gaucher Disease Key Players in Central & South America
    • 11.3 Central & South America Gaucher Disease Market Size by Type
    • 11.4 Central & South America Gaucher Disease Market Size by Application

    12 International Players Profiles

    • 12.1 Sanofi
      • 12.1.1 Sanofi Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Gaucher Disease Introduction
      • 12.1.4 Sanofi Revenue in Gaucher Disease Business (2014-2019)
      • 12.1.5 Sanofi Recent Development
    • 12.2 Shire
      • 12.2.1 Shire Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Gaucher Disease Introduction
      • 12.2.4 Shire Revenue in Gaucher Disease Business (2014-2019)
      • 12.2.5 Shire Recent Development
    • 12.3 Actelion Pharma
      • 12.3.1 Actelion Pharma Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Gaucher Disease Introduction
      • 12.3.4 Actelion Pharma Revenue in Gaucher Disease Business (2014-2019)
      • 12.3.5 Actelion Pharma Recent Development
    • 12.4 Pfizer
      • 12.4.1 Pfizer Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Gaucher Disease Introduction
      • 12.4.4 Pfizer Revenue in Gaucher Disease Business (2014-2019)
      • 12.4.5 Pfizer Recent Development
    • 12.5 ISU Pharm
      • 12.5.1 ISU Pharm Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Gaucher Disease Introduction
      • 12.5.4 ISU Pharm Revenue in Gaucher Disease Business (2014-2019)
      • 12.5.5 ISU Pharm Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Gaucher Disease market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Gaucher Disease status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gaucher Disease development in United States, Europe and China.

      The key players covered in this study
      Sanofi
      Shire
      Actelion Pharma
      Pfizer
      ISU Pharm
      ...

      Market segment by Type, the product can be split into
      Enzyme Replacement Therapy
      Substrate Reduction Therapy

      Market segment by Application, split into
      Non-Neuronopathic Gaucher Disease
      Neuronopathic Gaucher Disease

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Gaucher Disease status, future forecast, growth opportunity, key market and key players.
      To present the Gaucher Disease development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Gaucher Disease are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now